| Financial reports are an important basis for external investors to understand the company’s operating conditions and have an important impact on the credit foundation of the capital market.The authenticity and accuracy of financial reports are closely related to the interests of investors.Financial fraud will undoubtedly cause serious damage to the interests of investors.damage.With the continuous expansion of my country’s financial market,financial fraud cases occur frequently year by year,and the healthy development of pharmaceutical companies is related to the foundation of our country’s livelihood.Therefore,research on the causes and countermeasures of financial fraud in pharmaceutical companies is extremely important.The author draws inspiration from the punishment documents about accounting fraud in the pharmaceutical industry announced by the China Securities Regulatory Commission in recent years.The financial fraud case of Furen Pharmaceuticals has a huge amount of money involved and a bad social impact.This article makes an in-depth analysis of it.This paper adopts the case study method and uses the GONE theory to analyze the financial fraud of Furen Phannaceuticals.By collecting information such as punishment announcements published by the China Securities Regulatory Commission,annual reports of listed companies,and research reports on the pharmaceutical industry,the fraud incidents of the research target companies were sorted out.Taking Fu Jen Catholic Company as the starting point,the paper puts forward suggestions for the prevention of financial fraud in pharmaceutical enterprises,and makes a certain contribution to the enrichment of financial fraud prevention measures for pharmaceutical enterprises.This paper finds that in terms of greed factor,the senior management and major shareholders of Furen Pharmaceuticals have improper demands for personal interests,and profit from the company by inflating monetary funds and then inflating profits.In terms of opportunity factors,there are many unreasonable aspects of the governance structure of Furen Pharmaceuticals.The combination of two positions has resulted in a high concentration of power,and there are also loopholes in the company’s information system,and the internal control system is a mere formality.In terms of demand factor,in order to avoid delisting and maintain a good reputation to occupy more market share,the demand for market value management by equity pledge drives the management to risk fraud.In terms of exposure factors,Furen Pharmaceuticals is a typical multi-level collusion and fraud in which the management overrides internal control.Internal oversight agencies such as internal audit and the board of supervisors cannot effectively detect violations;external audit agencies are not rigorous enough to detect fraud,and small and medium-sized The awareness of shareholders’rights protection is very weak,and the punishment is too light to deter fraudsters.In response to the four problems,this paper proposes countermcasures.Establish a diversified employee performance evaluation system,put economic indicators such as long-term business results into the assessment indicators,and implement a mechanism of attribution and accountability to enhance employees’ sense of responsibility.To suppress from the perspective of fraud opportunities,first of all,it is necessary to optimize the company’s operation and management mechanism to check and balance the self-interested behavior of executives caused by the excessive concentration of management power;secondly,to establish a scientific internal control system and effectively implement and implement internal control.Suppressing fraudulent demand motives requires standardizing enterprise operation and management,improving the profitability of core businesses,building an internal accountability system,improving corporate governance structure,suppressing the self-interest motives of controlling shareholders,and cultivating entrepreneurs’ awareness of social responsibility.Increase the possibility of fraud and the exposure cost of fraud from multiple levels.At the enterprise level,improve the supervision and audit strength of internal audit and the independence of the internal audit department,encourage internal employees to report,and carry out science education on rights protection for small and medium investors in a timely manner;at the external institution level,it is necessary to improve the professional competence of audit firms and At the level of professional ethics,the synergy effect of media reports,public opinion and legal supervision needs to be achieved;at the regulatory level,it is necessary to improve the coordination of the supervision authority of the CSRC and the exchange,and delegate more authority to the front line of transactions,increasing the Punishment for financial fraud,broaden the scope of mandatory information disclosure by listed companies,enrich the standards for information disclosure,highlight the obligations and responsibilities of the company’s directors,supervisors,and controlling shareholders in information disclosure,and improve the transparency of listed companies’ information in many ways.The financial fraud incident of Furen Pharmaceuticals has caused serious damage to the company’s reputation,stock price decline and other consequences,and the rights and interests of investors have been damaged.Research on it will help safeguard the legitimate rights and interests of small and medium investors and promote the high-quality development of the national economy. |
PDF Full Text Request